Andexanet alfa for reversing anticoagulation from apixaban or rivaroxaban

Supporting evidence

• Evaluation report

• Appraisal consultation committee papers (PDF 8.28 MB)

  Published:

  12 May 2021

• Appraisal consultation 2 committee papers (PDF 2.56 MB)

  Published:

  12 May 2021

• Final appraisal determination committee papers (PDF 1.95 MB)

  Published:

  12 May 2021